Role of NSAIDs in acute treatment of headache

Drug Development Research

Volumn 68, Issue 6, 2007, Pages 276-281

  Martelletti, Paolo ^a   Farinelli, Ivano ^a   Coloprisco, Gabriella ^a   Patacchioli, Francesca Romana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute treatment; Headache; Medication overuse headache; NSAIDs; Trigeminal autonomic cephalgias

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; DICLOFENAC; DICLOFENAC POTASSIUM; ERGOT ALKALOID; IBUPROFEN; INDOMETACIN; KETOPROFEN; METOCLOPRAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PLACEBO; ROFECOXIB; SUMATRIPTAN; TRIPTAN DERIVATIVE;

ASTHMA; CHRONIC DAILY HEADACHE; CLINICAL TRIAL; DIGESTIVE SYSTEM PERFORATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; INCIDENCE; MIGRAINE; NAUSEA; NOTE; PAROXYSMAL HEMICRANIA; PHONOPHOBIA; PREVALENCE; TENSION HEADACHE; TRIGEMINAL AUTONOMIC CEPHALALGIA; VOMITING;

EID: 38149111142     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20191     Document Type: Note

References (51)

1. Baldassarre S, Schandene L, Choufani G, Michils A. 2006. Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen. J Allergy Clin Immunol 117:215-217.
2. Buring JE, Peto R, Hennekens CH. 1990. Low-dose aspirin for migraine prophylaxis. JAMA 264:1711-1713.
3. Buzzi MG, Formisano R. 2003. A patient with cluster headache responsive to indomethacin: any relationship with chronic paroxysmal hemicrania? Cephalalgia 23:401-404.
4. Castillo J, Munoz P, Guitera V, Pascual J. 1999. Epidemiology of chronic daily headache in the general population. Headache 39:190-196.
5. Codispoti JR, Prior MJ, Min Fu MS, Harte CM, Nelson EB. 2001. Efficacy of Nonprescription Doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache 41:665-679.
6. Cohen AS, Matharu MS, Goadsby PJ. 2007. Trigeminal autonomic cephalalgias: current and future treatments. Headache 47: 969-980.
7. Colás R, Munoz P, Temprano R, Gomez C, Pascual J. 2004. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338-1342.
8. Diclofenac-K/Sumatriptan Migraine Study Group. 1999. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac potassium, in comparison to oral sumatriptan and placebo. Cephalalgia 19:232-240.
9. Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Gobel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller-Schwefe G, Nappi G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M; EMSASI Study Group. 2004. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24:947-954.
10. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. 1993. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20:131-137.
11. Farinelli I, Martelletti P. 2007. Aspirin and tension-type headache. J Headache Pain 8:49-55.
12. Forward SP, McGrath PJ, MacKinnon D, Brown TL, Swann J, Currie EL. 1998. Medication patterns of recurrent headache sufferers: a community study. Cephalalgia 18:146-151.
13. Goldstein J, Silberstein S, Saper JR, Elkind AH, Smith TR, Gallagher M, Battikha JP, Hoffman H, Baggish J. 2005. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache 45:973-982.
14. Gorelick PB, Weisman SM. 2005. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 36:1801-1807.
15. Headache Classification Subcommittee of the International Headache Society. 2004. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 24(suppl 1):9-160.
16. Hernández-Diaz S, García-Rodríguez LA. 2006. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 4:22.
17. Iannazzo S, Cattaruzza MS, De Filippis S, Rossi F, Perata E, Di Rollo S, Coloprisco G, Martelletti P. 2003. Analgesic therapy for headache: consumption, appropriateness and costs. J Headache Pain 4:S84-S87.
18. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. 2003. Rate and predictors for relapse in medication overuse headache: a one vear prospective study. Neurology 60:1682-1684.
19. Katsarava Z, Müssig M, Dzagnidze A, Frische G, Diener HC, Limmroth V. 2005. Medication overuse headache: rates and predictors for relapse in a 4 year prospective study. Cephalalgia 25:12-15.
20. Kubitzek F, Ziegler G, Gold MS, Liu JMH, Ionescu E. 2002. Low-dose diclofenac potassium in the treatment of episodic tension-tvpe headache. Eur J Pain 7:155-162.
21. Kudrow L. 1989. Successful Aspirin prophylaxis in a child with chronic paroxismal hemicrania. Headache 29:280-281.
22. Lange R, Schwarz JA, Hohn M. 2000. Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 20:663-667.
23. Langemark M, Olesen J. 1987. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache 27:90-95.
24. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. 2005. Aspirin is efficacious for the treatment of acute migraine. Headache 45:283-292.
25. MacGregor EA, Dowson A, Davies PT. 2002. Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study. Headache 42:249-255.
26. Martelletti P, Steiner TJ, Bertolote JM, Dua T, Saraceno B. 2007. The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard. J Headache Pain 8:149-151.
27. Newman LC, Lipton RB, Solomon S, et al. 1994. Daily headache in a population sample: results from the American Migraine Study. Headache 34:295.
28. Pfaffenrath V, Scherzer S. 2005. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia S15:14-20.
29. Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P. 2005. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25:519-522.
30. Rapoport A. 2006. Acute treatment of headache. J Headache Pain 7:35.5-359.
31. Rasmussen BK. 2001. Epidemiology of headache. Cephalalgia 21: 774-777.
32. Relja G, Granato A, Capozzoli F, Maggiore C, Catalan M, Pizzolato G, Zalukar W, Livia V, Gregorutti S, Zorzon M. 2005. Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. J Headache Pain 6:298-300.
33. Ross-Lee LM, Eadie MJ, Heazlewood V, Bochner F, Tyrer JH. 1983. Aspirin pharmacokinetics in migraine. The effect of metoclopramide. Eur J Clin Pharmacol 24:777-785.
34. Saper JR, Hamel RL, Lake AE III. 2005. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 25:545-546.
35. Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, Barraclough E, Klipfel M, Lines C, Visser H, Reines S, Yuen E, and the Rofecoxib Protocol 162 Study Group. 2006. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Headache 46:264-275.
36. Schoenen J. 2001. When should triptans be taken during a migraine attack? CNS Drugs 15:583-587.
37. Serebruany VL, Stenhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, Topol EJ. 2005. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol 95:1218-1222.
38. Siow HC. 2004. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalgia 24:414-415.
39. Smith R. 2004. Chronic daily headache. Am Fam Physician 70:2299-2306.
40. Smith TR, Sunshine A, Stuart RS, Littlefield DE, Spruill SE, Alexander WJ. 2005. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45:983-991.
41. Steiner TJ, Lange R. 1998. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 18:38-43.
42. Steiner TJ, Lange R, Voelker M. 2003. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 23:59-66.
43. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. 2006. Epidemiology of headache in Europe. Eur J Neurol 13:333-345.
44. Stovner LJ, Hagen K, Katsarava Z, Lipton RB, Scher AI, Steiner TJ, Zwart J-A. 2007. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193-210.
45. Tfelt-Hansen P. 2007. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain 8:127-134.
46. Tfelt-Hansen P, Olesen J. 1984. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 4:107-111.
47. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235.
48. Von Seggern RL, Adelman JU. 1996. Cost considerations in headache treatment. Part 2. Acute migraine treatment. Headache 36:493-502.
49. Von Seggern RL, Mannix LK, Adelman JU. 2004. Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial. Headache 44:160-165.
50. World Health Organization. 2001. The world health report. Geneva: WHO. Chapter 2 [www.who.int/whr/2001/chapter2/en/index.html (accessed 26 Oct 2007).]
51. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. 2003. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 61:160-164.